Pure Global
NCT03005665

Effect of Acetazolamide on Optic Nerve Sheath Diameter in Laparoscopic Donor Nephrectomies

Effect of Orogastric Acetazolamide on Intraocular Pressure in Laparoscopic Donor Nephrectomies
Postgraduate Institute of Medical Education and Research·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intracranial Pressure Increase
Drug/Device/Intervention
Acetazolamide
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Postgraduate Institute of Medical Education and Research
Location
Chandigarh, India
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2016
End date
Dec 01, 2016
Enrollment
40 participants
Primary outcome

Change in Optic nerve sheath diameter being assessed

Summary

The purpose of the trial is to study the effect of acetazolamide administered via Ryle's tube
 on optic nerve sheath diameter in laparoscopic live donor nephrectomy patients.

ICD-10 classifications
Benign intracranial hypertensionIntracranial injuryIntracranial injury, unspecifiedOther intracranial injuriesIntracranial hypotension following ventricular shunting
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03005665
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03005665 through Pure Global AI's free database. This phase not specified trial is sponsored by Postgraduate Institute of Medical Education and Research and is currently Completed. The study focuses on Intracranial Pressure Increase. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.